Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.

Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2933-8. doi: 10.1073/pnas.0813361106. Epub 2009 Feb 5.

PMID:
19196989
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].

Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage JM.

Neurologia. 1991 Oct;6(8):287-94. Review. Spanish.

PMID:
1790005
[PubMed - indexed for MEDLINE]
3.

Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP.

Grünblatt E, Mandel S, Youdim MB.

Ann N Y Acad Sci. 2000;899:262-73. Review.

PMID:
10863545
[PubMed - indexed for MEDLINE]
4.

Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.

'Episcopo FL, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.

Curr Aging Sci. 2013 Feb;6(1):45-55. Review.

PMID:
23895521
[PubMed - indexed for MEDLINE]
5.

A guide to neurotoxic animal models of Parkinson's disease.

Tieu K.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316. doi: 10.1101/cshperspect.a009316. Review.

PMID:
22229125
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.

Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC.

Ann N Y Acad Sci. 2008 Dec;1147:61-9. doi: 10.1196/annals.1427.036. Review.

PMID:
19076431
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair.

Marchetti B, L'Episcopo F, Morale MC, Tirolo C, Testa N, Caniglia S, Serapide MF, Pluchino S.

Eur J Neurosci. 2013 May;37(10):1550-63. doi: 10.1111/ejn.12166. Epub 2013 Mar 5. Review.

PMID:
23461676
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.

Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1015-29. Review.

PMID:
23244425
[PubMed - indexed for MEDLINE]
9.

[Myeloperoxidase in the neurodegenerative process of Parkinson's disease].

Teismann P.

Dtsch Med Wochenschr. 2014 Jan;139(3):99-102. doi: 10.1055/s-0033-1359907. Epub 2013 Nov 25. Review. German.

PMID:
24277448
[PubMed - indexed for MEDLINE]
10.

[Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of Parkinson's disease].

Takahashi S, Seki M, Suzuki N.

Brain Nerve. 2013 Dec;65(12):1497-508. Review. Japanese.

PMID:
24323934
[PubMed - indexed for MEDLINE]
11.

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.

Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, Johnson JA.

Antioxid Redox Signal. 2009 Mar;11(3):497-508. doi: 10.1089/ARS.2008.2242. Review.

PMID:
18717629
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration.

Gupta K, Chandran S, Hardingham GE.

Br J Clin Pharmacol. 2013 Apr;75(4):907-18. doi: 10.1111/bcp.12022. Review.

PMID:
23126226
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Nrf2: a potential target for new therapeutics in liver disease.

Bataille AM, Manautou JE.

Clin Pharmacol Ther. 2012 Sep;92(3):340-8. doi: 10.1038/clpt.2012.110. Epub 2012 Aug 8. Review.

PMID:
22871994
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk